Ether

Ether

SCHEMBL6618296

CCOCC.[K+].[OH-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL11664673 0.90
Ether SCHEMBL17291816 0.90
Ether SCHEMBL29197006 0.90
Ether SCHEMBL9248674 0.89 ALDH1A1 (0.47)
Ether SCHEMBL8160191 0.89 ALDH1A1 (0.47)
Ether SCHEMBL21406 0.89 ALDH1A1 (0.47)
Ether SCHEMBL9248046 0.89 ALDH1A1 (0.47)
Ether SCHEMBL6 0.89
Ether SCHEMBL8322124 0.84 ALDH1A1 (0.44)
Ether SCHEMBL8391342 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112293750-A Selenium-rich protein powder 安徽草珊瑚生物科技有限公司 2021-02-02 CN claimed
CN-116712973-B Carbon-doped potassium titanate composite material and preparation method and application thereof 昆明理工大学 2024-01-23 CN disclosed
CN-116712973-A Carbon-doped potassium titanate composite material and preparation method and application thereof 昆明理工大学 2023-09-08 CN disclosed
CN-112293750-A Selenium-rich protein powder 安徽草珊瑚生物科技有限公司 2021-02-02 CN disclosed
CN-101906029-A Flavonoid derivative , preparation method thereof and use thereof UNIV SHANXI MEDICAL 2010-12-08 CN disclosed
CN-100374458-C 17aalpha-D-high valent alkyneestradiol-3-ethyl ester and its synthesis and preparation method, pharmaceutical composition using the said compound as active ingredient RADIOLOGY RES INST CHINESE ACA (CN) 2008-03-12 CN disclosed
CN-1765918-A The high alkynes estradiol of 17a α-D--3-ethyl ester and synthesis preparation method thereof and be the pharmaceutical composition of activeconstituents with this compound RADIOLOGY RES INST CHINESE ACA (CN) 2006-05-03 CN disclosed
EP-1490343-A1 NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS Neurogen Corporation (US) 2004-12-29 EP disclosed
WO-2003082829-A1 NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2003-10-09 WO disclosed
CN-1255119-A Protease inhibitors SMITHKLINE BEECHAM CORP (US) 2000-05-31 CN disclosed
CN-1097006-A The ether compound of O-aryl morphinan HOFFMANN LA ROCHE (CH) 1995-01-04 CN disclosed